Nephrotic Syndrome

被引：0
作者：
Chopra, Bhavna [1 ]
Thomas, Leslie [2 ]
机构：
[1] Allegheny Gen Hosp, Div Nephrol, Pittsburgh, PA 15212 USA
[2] Mayo Clin, Div Nephrol & Hypertens, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA
来源：
HOSPITAL MEDICINE CLINICS | 2014年 / 3卷 / 02期
关键词：
Nephrotic syndrome; Proteinuria; Edema; Minimal change disease; Focal segmental glomerulosclerosis; Membranous nephropathy;
D O I：
10.1016/j.ehmc.2013.11.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and membranous nephropathy (MN) are the most common causes of the nephrotic syndrome, diagnosed by demonstrating edema, proteinuria, hypoalbuminemia, and hyperlipidemia. MCD, FSGS, and MN vary by renal prognosis and known secondary causes. Renal biopsy is the gold standard for the proper diagnosis of MCD, FSGS, and MN. Management of the nephrotic syndrome is 2-fold: treatment of symptoms and complications (ie, edema, hyperlipidemia) and treatment of the underlying disease process (eg, corticosteroid therapy for primary diseases).
引用
收藏
页码：E245 / +
页数：12
相关论文
共 11 条
  • [1] Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis
    Barbour, Sean J.
    Greenwald, Allen
    Djurdjev, Ognjenka
    Levin, Adeera
    Hladunewich, Michelle A.
    Nachman, Patrick H.
    Hogan, Susan L.
    Cattran, Daniel C.
    Reich, Heather N.
    [J]. KIDNEY INTERNATIONAL, 2012, 81 (02) : 190 - 195
  • [2] M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy.
    Beck, Laurence H., Jr.
    Bonegio, Ramon G. B.
    Lambeau, Gerard
    Beck, David M.
    Powell, David W.
    Cummins, Timothy D.
    Klein, Jon B.
    Salant, David J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (01) : 11 - 21
  • [3] Deegens JKJ, 2008, NETH J MED, V66, P3
  • [4] Foreword
    Eckardt, Kai-Uwe
    Kasiske, Bertram L.
    [J]. KIDNEY INTERNATIONAL SUPPLEMENTS, 2012, 2 (01) : 7 - 7
  • [5] Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
    Genovese, Giulio
    Friedman, David J.
    Ross, Michael D.
    Lecordier, Laurence
    Uzureau, Pierrick
    Freedman, Barry I.
    Bowden, Donald W.
    Langefeld, Carl D.
    Oleksyk, Taras K.
    Knob, Andrea L. Uscinski
    Bernhardy, Andrea J.
    Hicks, Pamela J.
    Nelson, George W.
    Vanhollebeke, Benoit
    Winkler, Cheryl A.
    Kopp, Jeffrey B.
    Pays, Etienne
    Pollak, Martin R.
    [J]. SCIENCE, 2010, 329 (5993) : 841 - 845
  • [6] Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy
    Hofstra, Julia M.
    Beck, Laurence H., Jr.
    Beck, David M.
    Wetzels, Jack F.
    Salant, David J.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (06): : 1286 - 1291
  • [7] Venous Thromboembolism in Patients with Membranous Nephropathy
    Lionaki, Sophia
    Derebail, Vimal K.
    Hogan, Susan L.
    Barbour, Sean
    Lee, Taewoo
    Hladunewich, Michelle
    Greenwald, Allen
    Hu, Yichun
    Jennette, Caroline E.
    Jennette, J. Charles
    Falk, Ronald J.
    Cattran, Daniel C.
    Nachman, Patrick H.
    Reich, Heather N.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (01): : 43 - 51
  • [8] High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome
    Mahmoodi, Bakhtawar K.
    ten Kate, Min Ki
    Waanders, Femke
    Veeger, Nic J. G. M.
    Brouwer, Jan-Leendert P.
    Vogt, Liffert
    Navis, Gerjan
    van der Meer, Jan
    [J]. CIRCULATION, 2008, 117 (02) : 224 - 230
  • [9] PROGNOSIS OF UNTREATED PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY
    SCHIEPPATI, A
    MOSCONI, L
    PERNA, A
    MECCA, G
    BERTANI, T
    GARATTINI, S
    REMUZZI, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (02) : 85 - 89
  • [10] Schrier RW, 2012, SCHRIERS DIS KIDNEY
12